Coronavirus Notebook: UK Approves Novavax Vaccine, EMA Updates On Progress With Other Candidates
Executive Summary
With the approval of Nuvaxovid, the UK and the EU now each have five COVID-19 vaccines at their disposal. Meanwhile, the European Medicines Agency has given an estimated timeline for the approval of candidate vaccines from Valneva and Sanofi Pasteur, and is looking at which therapeutics could be effective against the Omicron variant. Russia says its Sputnik V vaccine has now been granted full regulatory approval there.
You may also be interested in...
Sputnik COVID-19 Vaccine Caught Up In Sanctions On Russia Over Ukraine Invasion
As Russia intensifies its invasion of Ukraine with missile attacks and a convoy of armored vehicles, the funder and promoter of the country’s COVID-19 vaccine, Sputnik V, has found itself the subject of punitive international sanctions alongside Russia’s Central Bank.
Ex-US FDA Official Petitions Agency To Stop Reviewing Applications From Russian Companies Amid War In Ukraine
The request could drag the agency back into a political arena it has been trying to avoid.
EU Approves Paxlovid For COVID-19
The European Medicines Agency’s assessment of the oral antiviral combination was conducted under the OPEN Initiative, which involves information sharing among international regulators.